Previous Article | Next Article ![]()
Journal of Virology, November 2001, p. 11249-11252, Vol. 75, No. 22
Wellcome Trust Centre for Human Genetics,
University of Oxford, Headington, Oxford OX3 7BN, United Kingdom
Received 21 May 2001/Accepted 15 August 2001
Epstein-Barr virus (EBV) oriP and the EBV nuclear
antigen 1 (EBNA-1) protein allow persistence of EBV-based
episomes. A nuclear matrix attachment region (MAR) spans
oriP and the adjacent region of the EBV genome
containing the EBV-expressed RNAs. Here, we show that episomes
with the MAR are retained significantly more efficiently in
EBV-positive B cells than episomes containing oriP alone.
Epstein-Barr virus (EBV) is a
lymphotrophic gammaherpesvirus that is capable of lifelong persistence
as an episome in human B cells. In combination with the EBV nuclear
antigen 1 (EBNA-1) gene, a 1.8-kb region of the EBV genome designated
oriP is sufficient in cis for retention and
replication of plasmids in eukaryotic cells (19, 20).
However, oriP-based episomes are gradually lost from
continuously dividing cultures in the absence of selective pressure for
their retention. Here, we study the effect of sequences adjacent to
oriP on episome retention.
oriP consists of two major functional regions (reviewed in
reference 10). The family of repeats (FR) is composed of
20 imperfect copies of a 30-bp repeat, each of which binds an EBNA-1
dimer. The FR is separated by 1 kb from a region of dyad symmetry (DS) which contains a further four EBNA-1 binding sites. The FR and EBNA-1
protein are essential for episomal maintenance, while the DS acts as an
EBNA-1-dependent replication origin (1). Plasmids carrying
the FR alone fail to undergo DNA replication (9), unless
they contain an alternative source of replication origins, such as
genomic DNA (3, 9) or other EBV sequences (7, 12), which only uses the cellular replication machinery.
Analysis of the viral genome in Raji cells, an EBV-positive Burkitt's
lymphoma (BL) cell line, has shown that EBV is attached to the nuclear
matrix. The matrix attachment region (MAR) of EBV extends over both
oriP and the adjacent EBV-expressed RNA (EBER) genes
(6). The EBER genes do not encode protein and have
not been ascribed a function although they are transcribed by RNA polymerase III throughout viral latency. They are primarily associated with the rough endoplasmic reticulum but associate with the chromosomes during metaphase (14). The EBER genes can be deleted from
EBV without abrogating its ability to infect, transform, and either remain latently stable within B lymphocytes or enter the lytic cycle
(15). However, a recent study suggests that the EBER genes may play a role in blocking cellular apoptosis, thereby promoting oncogenicity in BL (8).
We have previously shown that EBV episomes can carry large genomic DNA
inserts for prolonged periods in cell culture (16) and
that genomic DNA transgenes can be functionally expressed from these
episomes in mammalian cell culture (17). Here, we investigate the functional significance of the MAR that spans oriP and includes the EBER genes, with a view to improved
understanding of EBV episomal systems.
We constructed a series of mini-EBV replicons containing a 60-kb human
genomic DNA insert and three variants of oriP (Fig. 1). The mini-EBV plasmid amplicons
(pmEBV) contained oriP, defined as positions 7338 to 9520 in
the B95-8 strain (19, 20). The amplicon pmEBV-EBER (Fig.
1) contains EBV DNA from position 4948 to 9520, which includes
oriP and the entire region previously defined as attached to
the nuclear matrix. pmEBV-
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.22.11249-11252.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Sequences Adjacent to oriP Improve
the Persistence of Epstein-Barr Virus-Based Episomes in B
Cells

and
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
DS is the same as pmEBV with the DS
removed by excision of the EcoRV/HpaI 140-bp fragment. All plasmids also contained the EBV terminal repeats, oriLyt and an EBNA-1 expression cassette. To allow the
tracking of the episome in mammalian cells, expression cassettes for
enhanced green fluorescent protein (GFP) and hygromycin
phosphotransferase were included.

View larger version (27K):
[in a new window]
FIG. 1.
Structure of episomal plasmid pmEBV-EBER. Expression
cassettes for GFP and hygromycin phosphotransferase
(hph) are indicated. Hatched arrows, promoters; black
arrows, genes. EBV elements (grey) included are oriP (FR
and DS regions), EBER1 and -2, EBNA-1, the terminal repeats, the
lytic origin of replication (oriLyt), and the adjacent
internal repeat 2 site (IR2). Genomic DNA (the
insert from PAC 220G18; Research Genetics) was cloned into the
NotI site indicated. Bacterial elements (white arrows)
are shown. pmEBV lacks the EBV region flanked by the
NruI and EcoRI sites indicated.
pmEBV-
DS also lacks the DS region, which was excised at the
EcoRV and HpaI sites closely flanking the
DS.
The vectors were transfected into HH514 cells, a BL cell line
that contains a nontransforming strain of EBV (13), using a peptide-Lipofectin reagent described elsewhere (2).
Transfected cells were selected with hygromycin B, and several
clonal cell lines were isolated by dilution cloning: three
carried pmEBV (HHmE-C1-3), three carried pmEBV-EBER
(HHmE-EBER-C1-3), and one carried pmEBV-
DS (HHmE
DS-C1). DNA
was isolated from these lines and was transformed into bacteria to
recover the episome, using protocols described elsewhere
(16). All episomes rescued from all of the HHmE and HHmE-EBER cell lines were identical to the original plasmid. Five of
six rescued episomes analyzed from HHmE
DS-C1 were unaltered, but one
appeared to have undergone a deletion of part of its genomic DNA insert
(results not shown). Copy number analysis by quantitative Southern
blotting of genomic DNA from the human cell lines (17) indicated that they carried between 35 and 64 episomes per cell (Table
1). The presence of the EBV genome in
HH514 cells prevented the direct detection of EBER genes attributable
to the introduced episomes in this cell line. However, EBER expression
was detected from the pmEBV-EBER construct by Northern blot analysis,
following transfection of the plasmid into EBV-negative 293 cells (not
shown).
|
We then grew each cell line in both the presence and absence of
hygromycin B selection. Every 5 days, flow cytometry was used to
measure the proportion of cells expressing GFP and hence carrying the
episome (Fig. 2). The loss of GFP
expression allowed us to follow the loss of episome and thus to
quantify episome retention efficiency. In these experiments, we assume
that green fluorescence equates to episomal status because we did not
observe a plateau phenomenon or reduction in fluorescence typical of
cells in which an integration event has significantly outgrown the
population (16). A cell was defined as green if it
fluoresced more strongly than 99.5% of untransfected HH514 cells. The
loss of green fluorescence of a cell only begins to occur once it has
lost all episomes and when preexisting GFP protein degrades, so a
change in their green status will lag somewhat behind the loss of the
episome. To model this, the data was fitted with a line of the form
y = aeb(x
c)
where y is the number of generations and x is the
percentage of cells which remain green. The constant a is
the percentage of green cells at the start of the relaxation,
b is the rate of episome loss in terms of the proportion of
cells losing the episome each generation, and c is the lag
time in generations.
|
The results shown in Fig. 2 and Table 1 indicate that episomes containing the MAR are retained significantly more efficiently than those lacking the EBER genes (P = 0.0007 by the Student t test), despite the slightly lower episome copy number of the pmEBV-EBER construct. Thus, the half-life of episome-carrying cells in the absence of selective pressure almost doubles, from approximately 25 to 49 cell divisions (31 to 61 days). The episome in which the DS was deleted from oriP was lost at a rate similar to those retaining a full oriP. These latter data are consistent with recent results for a recombinant EBV deleted for the DS, which was lost at the same rate as virus with wild-type oriP (12). We have not tested the effect of deletion of the DS in the presence of the MAR.
Unexpectedly, the HHmE-EBER cell lines consistently expressed a higher level of GFP (reflected by the value of a) (Table 1), although it does not influence the calculations of episome retention. This may be mediated by the transcription factor binding sequences in the regulatory elements of the EBER genes (4), either acting alone or in conjunction with FR. It is unlikely that the EBER transcripts are directly responsible for this effect, as the HH514 cells express EBER genes from their native virus in all of the cell lines studied. It may be interesting to assess whether a similar effect is observed for EBV promoters that are activated by FR, such as the EBNA genes' promoter, pC, and the latent membrane protein 1 promoter.
This study has not established whether the improved retention of oriP-MAR requires EBV in trans. Since the EBER genes are expressed by the EBV genome in HH514 cells in all the cell lines studied, we can conclude that the presence of the EBER genes (or nearby DNA elements) in cis significantly improves the retention of EBV-based episomes. These elements may or may not require the presence of the EBER RNAs themselves. Further study of these episomes in an EBV-negative cell line could address this question. Alternatively, EBER genes minimally mutated to abrogate expression (18) could be useful reagents to probe their role in episome retention.
A recent report has shown that the EBV region spanning positions 6400 to 8300 exhibits an extremely high sensitivity to micrococcal nuclease, indicating either an unusual nucleosome structure or a complete absence of nucleosomes (18). This region includes the FR and both EBER genes (but not the DS) and is entirely contained within both the previously defined MAR (6) and the region mediating improved episome retention described herein. Taken together, these data suggest that the region of the EBV genome covering the EBER genes and the FR adopts an unusual structure that promotes association with the nuclear matrix. This may be mechanistically related to metaphase chromosome association, which is critical in episome maintenance (5).
Recent results from Leight and Sugden (11) reinforce this hypothesis. The authors found that a stochastic, epigenetic event is required for efficient partitioning of oriP plasmids (11), for which they invoke a mechanism involving chromatin configuration. Given that sites of transcriptional regulation and origins of replication are often clustered around cellular and viral MARs (6), incorporation of the point mutations used by Wensing et al. (18) to modulate the EBER promoter in our vector would be an elegant test of this hypothesis. Further elucidation of the cis and trans elements that promote these effects promises to enhance our understanding of episomal maintenance, nuclear matrix attachment, and EBV nucleosome organization and also holds the promise of improved episomal gene transfer vectors.
| |
ACKNOWLEDGMENTS |
|---|
We thank Bill Sugden for the gift of plasmids used in vector construction, George Miller for providing HH514 cells, Jon Frampton for the use of his FACScalibur cell counter, and Steve Hart for provision of peptide for transfections.
R.W.-M. was a Wellcome Trust Prize Fellow.
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: Queensland Institute of Medical Research, 300 Herston Rd., Q 4006 Brisbane, Australia. Phone: 61-7-3362-0218. Fax: 61-7-3362-0101. E-mail: michaelJ{at}qimr.edu.au.
Present address: St. James's University Hospital, Leeds LS9 7TF,
United Kingdom.
Present address: Massachusetts General Hospital, Harvard Medical
School, Charlestown, MA 02129.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Gahn, T. A., and C. L. Schildkraut. 1989. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58:527-535[CrossRef][Medline]. |
| 2. | Hart, S. L., C. V. Arancibia-Carcamo, M. A. Wolfert, C. Mailhos, N. J. O. O'Reilly, R. R. Ali, C. Coutelle, A. J. T. George, R. P. Harbottle, A. M. Knight, D. F. P. Larkin, R. J. Levinsky, L. W. Seymour, A. J. Thrasher, and C. Kinnon. 1998. Lipid-mediated enhancement of transfection by a nonviral integrin targeting vector. Hum. Gene Ther. 9:575-585[Medline]. |
| 3. |
Heinzel, S. S.,
P. J. Krysan,
C. T. Tran, and M. P. Calos.
1991.
Autonomous DNA replication in human cells is affected by the size and the source of the DNA.
Mol. Cell. Biol.
11:2263-2272 |
| 4. |
Howe, J. G., and M.-D. Shu.
1988.
Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs.
J. Virol.
62:2790-2798 |
| 5. |
Hung, S. C.,
M.-S. Kang, and E. Kieff.
2001.
Maintenance of Epstein-Barr virus (EBV) oriP episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-1 or histone H1.
Proc. Natl. Acad. Sci. USA
98:1865-1870 |
| 6. | Jankelevich, S., J. L. Kolman, J. W. Bodnar, and G. Miller. 1992. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J. 11:1165-1176[Medline]. |
| 7. | Kirchmaier, A., and B. Sugden. 1998. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J. Virol. 69:1280-1283[Abstract]. |
| 8. |
Komano, J.,
S. Maruo,
K. Kurozumi,
T. Oda, and K. Takada.
1999.
Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.
J. Virol.
73:9827-9831 |
| 9. |
Krysan, P. J.,
S. B. Haase, and M. P. Calos.
1989.
Isolation of human sequences that replicate autonomously in human cells.
Mol. Cell. Biol.
9:1026-1033 |
| 10. | Leight, E. R., and B. Sugden. 2000. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10:83-100[CrossRef][Medline]. |
| 11. |
Leight, E. R., and B. Sugden.
2001.
Establishment of an oriP replication is dependent upon an infrequent, epigenetic event.
Mol. Cell. Biol.
21:4149-4161 |
| 12. |
Norio, P.,
C. L. Schildkraut, and J. L. Yates.
2000.
Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
J. Virol.
74:8563-8574 |
| 13. |
Rabson, M.,
L. Heston, and G. Miller.
1983.
Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells.
Proc. Natl. Acad. Sci. USA
80:2762-2766 |
| 14. |
Schwemmle, M.,
M. J. Clemens,
K. Hilse,
K. Pfeifer,
H. Tröster,
W. E. G. Müller, and M. Bachmann.
1992.
Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells.
Proc. Natl. Acad. Sci. USA
89:10292-10296 |
| 15. |
Swaminathan, W.,
B. Tomkinson, and E. Kieff.
1991.
Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
Proc. Natl. Acad. Sci. USA
88:1546-1550 |
| 16. |
Wade-Martins, R.,
J. Frampton, and M. R. James.
1999.
Long term stability of episomal vectors carrying large genomic DNA inserts in human cells.
Nucleic Acids Res.
27:1674-1682 |
| 17. | Wade-Martins, R., R. E. White, H. Kimura, P. Cook, and M. R. James. 2000. Stable correction of a genetic deficiency in human cells by a 115 kb episomal genomic transgene. Nat. Biotechnol. 18:1311-1314[CrossRef][Medline]. |
| 18. |
Wensing, B.,
A. Stühler,
P. Jenkins,
M. Hollyoake,
C. E. Karestegl, and P. J. Farrell.
2001.
Variant chromatin structure of oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP.
J. Virol.
75:6235-6241 |
| 19. |
Yates, J.,
N. Warren,
D. Reisman, and B. Sugden.
1984.
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.
Proc. Natl. Acad. Sci. USA
81:3806-3810 |
| 20. | Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812-815[CrossRef][Medline]. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»